| abstract |
Peptides form the human kininogen D5 domain and fusion peptides thereof having angiogenesis-inhibitory activity. These peptides are used in diagnosis and therapy of diseases associated with endothelial cell migration and proliferation, e.g., the treatment of cancer. The invention further relates to nucleic acid molecules encoding said peptides, antibodies to the said peptides and methods for isolating said peptides and cells expressing them. |